PPARγ can enhance lipid accumulation in adipocytes, thereby causing lipid metabolism disorders, such as elevated TG levels and reduced high-density lipoprotein cholesterol (HDL-C) levels [21, 22]. Here, PPARG is linked to Disorder of lipid metabolism.